Confirmed Activity and Tolerability of Weekly Paclitaxel in the Treatment of Advanced Angiosarcoma

Background. In several prospective and retrospective studies, weekly paclitaxel showed promising activity in patients with angiosarcoma. Patients and Methods. Our study was originally designed as a prospective, phase II multicenter trial for patients younger than 75, with ECOG performance status 0–2...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Sarcoma
Главные авторы: Apice, Gaetano, Pizzolorusso, Antonio, Di Maio, Massimo, Grignani, Giovanni, Gebbia, Vittorio, Buonadonna, Angela, De Chiara, Annarosaria, Fazioli, Flavio, De Palma, Giampaolo, Galizia, Danilo, Arcara, Carlo, Mozzillo, Nicola, Perrone, Francesco
Формат: Artigo
Язык:Inglês
Опубликовано: Hindawi Publishing Corporation 2016
Предметы:
Clinical Study
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4785388/
https://ncbi.nlm.nih.gov/pubmed/27019606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/6862090
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы